Related Experiment Video
Updated: Jul 19, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Virological and clinical implications of resistance to HIV-1 protease inhibitors
1Department of Antiviral Research, Merck Research Laboratories, West Point, PA 19486, USA. jon_condra@merck.com
Abstract:
Resistance to HIV-1 protease inhibitors is associated with 25 or more amino acid substitutions in the protease and its cleavage sites. These appear in variable combinations and in different orders, and their effects depend on the combinations in which they occur. Substitutions within and away from the enzyme active site may engender resistance by drug-specific or drug-independent mechanisms. The correlates of resistance to the different protease inhibitors overlap substantially, and each can select for viral variants that are cross-resistant to others. An understanding of protease inhibitor resistance is critical for the appropriate use of these potent inhibitors of viral replication.
More Related Videos
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Retrovirus Life Cycles
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors
Clinical Significance of Antibiotic Resistance
Viral Mutations

